Teva Pharmaceutical Industries Ltd ADR buy Barclays PLC
Start price
05.02.24
/
50%
€11.45
Target price
05.02.25
€15.82
Performance (%)
14.85%
Price
22:26
€13.15
Summary
This prediction is currently active. The prediction currently has a performance of 14.85%. This prediction currently runs until 05.02.25. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Teva Pharmaceutical Industries Ltd ADR | 8.197% | 8.197% |
| iShares Core DAX® | -0.992% | -3.231% |
| iShares Nasdaq 100 | -0.225% | -3.339% |
| iShares Nikkei 225® | -0.736% | -7.859% |
| iShares S&P 500 | -0.509% | -2.979% |
Comments by Barclays_PLC for this prediction
In the thread Teva Pharmaceutical Industries Ltd ADR diskutieren
Teva Pharmaceutical Industries Limited (NYSE: TEVA) had its price target raised by analysts at Barclays PLC from $15.00 to $17.00. They now have an "overweight" rating on the stock.
Ratings data for TEVA provided by MarketBeat
Stopped prediction by Barclays_PLC for Teva Pharmaceutical Industries Ltd ADR
Teva Pharmaceutical Industries Ltd ADR
Start price
Target price
Perf. (%)
€11.00
29.01.24
29.01.24
€13.86
29.01.25
29.01.25
19.55%
22:26
22:26
